Glaxo Group Limited 2005. Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors. WO 2005014552. [Patent]. |
Official URL: https://patents.google.com/patent/WO2005014552A1/e...
Abstract
Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.
Item Type: | Patent |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Subjects: | R Medicine > R Medicine (General) |
Uncontrolled Keywords: | quinoline; quinazoline |
Last Modified: | 24 Oct 2022 08:45 |
URI: | https://orca.cardiff.ac.uk/id/eprint/118604 |
Actions (repository staff only)
Edit Item |